Alternatives to Alpha Tau Medical

Advancing targeted alpha therapies.

Global leader in cancer care, providing advanced technologies for radiotherapy and oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Accelerating the development of breakthrough new medicines and medical technologies.

AI-powered blood test for early cancer detection and subtyping.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.